Table 1.
Demographic and clinical patients’ characteristics
| Total cases, n | 122 |
| Sex, n (%) | |
| Male | 74 (60.7) |
| Female | 48 (39.3) |
| Age, mean (± SD), years | 63 (± 10.1) |
| BMI, n (%) | |
| 18.5 < BMI < 24.9 | 45 (36.9) |
| 25 < BMI < 30 | 51 (41.8) |
| BMI > 30 | 26 (21.3) |
| ASA score, n (%) | |
| ASA 1 | 40 (32.8) |
| ASA2 | 60 (49.2) |
| ASA 3 | 17 (13.9) |
| ASA4 | 5 (4.1) |
| Pre-operative clinical staging, n (%) | |
| cT1N0 | 14 (11.5) |
| cT1N1 | 9 (7.4) |
| cT2N0 | 18 (14.7) |
| cT2N1 | 9 (7.3) |
| cT2N2 | 7 (5.7) |
| cT3N0 | 20 (16.4) |
| cT3N1 | 17 (13.9) |
| cT3N2 | 15 (12.3) |
| cT4N0 | 8 (6.5) |
| cT4N1 | 4 (3.3) |
| cT4N2 | 1 (1) |
| Location of the tumor in the rectum, n (%) | |
| High | 29 (23.8) |
| Middle | 54 (44.3) |
| Low | 39 (32) |
| Neoadjuvant therapy, n (%) | 73 (59.8) |
| Long-course radiochemotherapy | 61 |
| Short-course radiotherapy | 11 |
| Chemotherapy alone | 1 |
| Previous abdominal surgery, n (%) | 22 (18) |